SCHEMBL9628046

SCHEMBL9628046

COC1=C(C(C)C)C(=O)c2ccccc2C1=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.68
ALDH1A1 P00352 8/20 0.68
CDC25B P30305 8/20 0.68
CDC25A P30304 7/20 0.68
POLB P06746 7/20 0.68
KDM4E B2RXH2 6/20 0.68
LMNA P02545 5/20 0.68
HPGD P15428 5/20 0.68
SMN1; SMN2 Q16637 5/20 0.68
TDP1 Q9NUW8 4/20 0.68
RAB9A P51151 4/20 0.68
MAP2K7 O14733 1/20 0.68
GMNN O75496 1/20 0.68
TP53 P04637 1/20 0.68
CYP1A2 P05177 1/20 0.68
CYP3A4 P08684 1/20 0.68
CYP2D6 P10635 1/20 0.68
CYP2C9 P11712 1/20 0.68
ALOX15 P16050 1/20 0.68
CYP2C19 P33261 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29545010 0.82 MAPT (1.00) MAPTALDH1A1CDC25BCDC25APOLB
SCHEMBL571557 0.82 MAPT (1.00) MAPTALDH1A1CDC25BCDC25APOLB
SCHEMBL9628085 0.82 MAPT (0.49) MAPTALDH1A1CDC25BCDC25APOLB
SCHEMBL9627635 0.81 MAPT (0.59) MAPTALDH1A1CDC25BCDC25APOLB
SCHEMBL5589809 0.77 CDC25A (0.44) MAPTALDH1A1CDC25BCDC25APOLB
SCHEMBL17520517 0.76 MAPT (0.52) MAPTALDH1A1CDC25BCDC25APOLB
SCHEMBL3414838 0.76 CDC25B (1.00) MAPTALDH1A1CDC25BCDC25APOLB
SCHEMBL30002742 0.76 CDC25B (1.00) MAPTALDH1A1CDC25BCDC25APOLB
SCHEMBL5811059 0.75 CDC25B (0.47) MAPTALDH1A1CDC25BCDC25APOLB
SCHEMBL22874151 0.74 CDC25B (0.54) MAPTALDH1A1CDC25BCDC25APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155132-A Nonsteroidal antiinflammatory agents; treating psoriasis SYNTEX (U.S.A.) INC. (US) 1992-10-13 US disclosed
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 US disclosed
US-5089657-A Topical antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-02-18 US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
EP-0282056-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
US-4758587-A Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-07-19 US disclosed